| Financial Year |
March 31 2022 |
| Monetary Funds |
115,011,569.53 |
| Held-for-trading Financial Assets |
381.55 |
| Notes Receivable |
-- |
| Accounts Receivable |
16,022,693.49 |
| Advances to Suppliers |
5,252,896.95 |
| Other Receivables |
827,212.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
836,949.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,438,905.11 |
| Total Current Assets |
187,268,328.11 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
33,093,769.03 |
| Investment Properties |
-- |
| Fixed Assetes |
109,269,274.74 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,266,417.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
318,175.26 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
220,716,117.67 |
| Sub-Total of Non-Current Assets |
374,858,802.37 |
| Total Assets |
562,127,130.48 |
| Short-Term Loans |
23,033,843.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
61,891,088.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,511,481.70 |
| Taxes Payable |
2,300,253.51 |
| Interest Payable |
-- |
| Dividend Payable |
597,293.22 |
| Other payables |
137,222,259.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
112,852.21 |
| Sub-Total of Current Liabilities |
236,744,330.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,780.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
174,101.78 |
| Total Liabilities |
236,918,431.79 |
| Paid-In Capital(Or Share Stock) |
439,011,169.00 |
| Capital Surplus |
20,960,419.50 |
| Surplus Reserve |
42,510,893.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-165,320,190.19 |
| Minority Stockholder's Interest |
485,319.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
324,723,378.77 |
| Owner's Equity（Stockholder's Equity） |
325,208,698.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
562,127,130.48 |
